Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ludwig

Showing results (361-370 of 595) with videos related to

Pageof 60
Sort By:
Genomics|October 1, 1991
Pro-347-Arg mutation of the rhodopsin gene in autosomal dominant retinitis pigmentosaA Gal, A Artlich, M Ludwig, et al.
Archives of General Psychiatry|April 1, 1972
The objective study of a multiple personality. Or, are four heads better than one?A M Ludwig, J M Brandsma, C B Wilbur, et al.
Cancer Medicine|August 21, 2019
Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver diseaseCortlandt M Sellers, Johannes Uhlig, Johannes M Ludwig, et al.
Atherosclerosis|June 25, 1999
The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatmentG Riegger, C Abletshauser, M Ludwig, et al.
Epidemiology and Infection|December 16, 2010
Assessment of varicella vaccine effectiveness in Germany: a time-series approachM Höhle, A Siedler, H-M Bader, et al.
Reproductive Biomedicine Online|April 12, 2008
Attitudes towards disclosure of conception mode in 899 pregnancies conceived after ICSIAk Ludwig, A Katalinic, J Jendrysik, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 18, 2006
Expression of the long form of the prolactin receptor in magnocellular oxytocin neurons is associated with specific prolactin regulation of oxytocin neuronsI C Kokay, P M Bull, R L Davis, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
Oncolytic virus immunotherapy: future prospects for oncologyJunaid Raja, Johannes M Ludwig, Scott N Gettinger, et al.
Molecular Oncology|June 6, 2016
SW43-DOX ± loading onto drug-eluting bead, a potential new targeted drug delivery platform for systemic and locoregional cancer treatment - An in vitro evaluationJohannes M Ludwig, Yongkang Gai, Lingyi Sun, et al.
Molecular Pharmaceutics|July 13, 2017
Targeted Yttrium 89-Doxorubicin Drug-Eluting Bead-A Safety and Feasibility Pilot Study in a Rabbit Liver Cancer ModelJohannes M Ludwig, Minzhi Xing, Yongkang Gai, et al.
Pageof 60

Showing results (361-370 of 595) with videos related to

Sort By:
Pageof 60
Genomics|October 1, 1991
Pro-347-Arg mutation of the rhodopsin gene in autosomal dominant retinitis pigmentosaA Gal, A Artlich, M Ludwig, et al.
Archives of General Psychiatry|April 1, 1972
The objective study of a multiple personality. Or, are four heads better than one?A M Ludwig, J M Brandsma, C B Wilbur, et al.
Cancer Medicine|August 21, 2019
Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver diseaseCortlandt M Sellers, Johannes Uhlig, Johannes M Ludwig, et al.
Atherosclerosis|June 25, 1999
The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatmentG Riegger, C Abletshauser, M Ludwig, et al.
Epidemiology and Infection|December 16, 2010
Assessment of varicella vaccine effectiveness in Germany: a time-series approachM Höhle, A Siedler, H-M Bader, et al.
Reproductive Biomedicine Online|April 12, 2008
Attitudes towards disclosure of conception mode in 899 pregnancies conceived after ICSIAk Ludwig, A Katalinic, J Jendrysik, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 18, 2006
Expression of the long form of the prolactin receptor in magnocellular oxytocin neurons is associated with specific prolactin regulation of oxytocin neuronsI C Kokay, P M Bull, R L Davis, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
Oncolytic virus immunotherapy: future prospects for oncologyJunaid Raja, Johannes M Ludwig, Scott N Gettinger, et al.
Molecular Oncology|June 6, 2016
SW43-DOX ± loading onto drug-eluting bead, a potential new targeted drug delivery platform for systemic and locoregional cancer treatment - An in vitro evaluationJohannes M Ludwig, Yongkang Gai, Lingyi Sun, et al.
Molecular Pharmaceutics|July 13, 2017
Targeted Yttrium 89-Doxorubicin Drug-Eluting Bead-A Safety and Feasibility Pilot Study in a Rabbit Liver Cancer ModelJohannes M Ludwig, Minzhi Xing, Yongkang Gai, et al.
Pageof 60